Literature DB >> 25042198

Time-dependent effects of hydrophobic amine-containing drugs on lysosome structure and biogenesis in cultured human fibroblasts.

Randall Logan1, Alex C Kong, Jeffrey P Krise.   

Abstract

Many weakly basic amine-containing drugs are known to be extensively sequestered in acidic lysosomes by an ion trapping-type mechanism. The entrapment of drugs in lysosomes has been shown to influence drug activity, cancer cell selectivity, and pharmacokinetics and can cause the hyperaccumulation of various lipids associated with lysosomes. In this work, we have investigated the prolonged time-dependent effects of drugs on lysosomal properties. We have evaluated two amine-containing drugs with intermediate (propranolol) and high (halofantrine) relative degrees of lipophilicity. Interestingly, the cellular accumulation kinetics of these drugs exhibited a biphasic characteristic at therapeutically relevant exposure levels with an initial apparent steady-state occurring at 2 days followed by a second stage of enhanced accumulation. We provide evidence that this secondary drug accumulation coincides with the nuclear localization of transcription factor EB, a master regulator of lysosome biogenesis, and the appearance of an increased number of smaller and lipid-laden lysosomes. Collectively, these results show that hydrophobic lysosomotropic drugs can induce their own cellular accumulation in a time-dependent fashion and that this is associated with an expanded lysosomal volume. These results have important therapeutic implications and may help to explain sources of variability in drug pharmacokinetic distribution and elimination properties observed in vivo.
© 2014 Wiley Periodicals, Inc. and the American Pharmacists Association.

Entities:  

Keywords:  cell culture; chronopharmacokinetics; lipids; nonlinear pharmacokinetics; pharmacokinetics; physicochemical properties

Mesh:

Substances:

Year:  2014        PMID: 25042198     DOI: 10.1002/jps.24087

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  12 in total

1.  An Expandable Mechanopharmaceutical Device (3): a Versatile Raman Spectral Cytometry Approach to Study the Drug Cargo Capacity of Individual Macrophages.

Authors:  Vernon LaLone; Márcio A Mourão; Theodore J Standiford; Krishnan Raghavendran; Kerby Shedden; Kathleen A Stringer; Gus R Rosania
Journal:  Pharm Res       Date:  2018-11-06       Impact factor: 4.200

2.  Detecting ordered small molecule drug aggregates in live macrophages: a multi-parameter microscope image data acquisition and analysis strategy.

Authors:  Phillip Rzeczycki; Gi Sang Yoon; Rahul K Keswani; Sudha Sud; Kathleen A Stringer; Gus R Rosania
Journal:  Biomed Opt Express       Date:  2017-01-13       Impact factor: 3.732

3.  GNS561, a new lysosomotropic small molecule, for the treatment of intrahepatic cholangiocarcinoma.

Authors:  Sonia Brun; Firas Bassissi; Cindy Serdjebi; Marie Novello; Jennifer Tracz; François Autelitano; Marie Guillemot; Philippe Fabre; Jérôme Courcambeck; Christelle Ansaldi; Eric Raymond; Philipe Halfon
Journal:  Invest New Drugs       Date:  2019-02-19       Impact factor: 3.850

4.  Clofazimine Biocrystal Accumulation in Macrophages Upregulates Interleukin 1 Receptor Antagonist Production To Induce a Systemic Anti-Inflammatory State.

Authors:  Gi S Yoon; Rahul K Keswani; Sudha Sud; Phillip M Rzeczycki; Mikhail D Murashov; Tony A Koehn; Theodore J Standiford; Kathleen A Stringer; Gus R Rosania
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

Review 5.  Transcription factor EB: from master coordinator of lysosomal pathways to candidate therapeutic target in degenerative storage diseases.

Authors:  Marco Sardiello
Journal:  Ann N Y Acad Sci       Date:  2016-05       Impact factor: 5.691

6.  A beta-blocker, propranolol, decreases the efficacy from enzyme replacement therapy in Pompe disease.

Authors:  Sang-Oh Han; Rand Pope; Songtao Li; Priya S Kishnani; Richard Steet; Dwight D Koeberl
Journal:  Mol Genet Metab       Date:  2015-10-03       Impact factor: 4.797

7.  Reverse Engineering the Intracellular Self-Assembly of a Functional Mechanopharmaceutical Device.

Authors:  Tehetina Woldemichael; Rahul K Keswani; Phillip M Rzeczycki; Mikhail D Murashov; Vernon LaLone; Brian Gregorka; Joel A Swanson; Kathleen A Stringer; Gus R Rosania
Journal:  Sci Rep       Date:  2018-02-13       Impact factor: 4.379

8.  The Lysosomotropic Activity of Hydrophobic Weak Base Drugs is Mediated via Their Intercalation into the Lysosomal Membrane.

Authors:  Michal Stark; Tomás F D Silva; Guy Levin; Miguel Machuqueiro; Yehuda G Assaraf
Journal:  Cells       Date:  2020-04-27       Impact factor: 6.600

9.  Autophagic flux inhibition and lysosomogenesis ensuing cellular capture and retention of the cationic drug quinacrine in murine models.

Authors:  Alexandre Parks; Xavier Charest-Morin; Michael Boivin-Welch; Johanne Bouthillier; Francois Marceau
Journal:  PeerJ       Date:  2015-10-06       Impact factor: 2.984

10.  The physiological determinants of drug-induced lysosomal stress resistance.

Authors:  Tehetina Woldemichael; Gus R Rosania
Journal:  PLoS One       Date:  2017-11-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.